Literature DB >> 27500691

Synthesis of novel lupane triterpenoid-indazolone hybrids with oxime ester linkage.

Tatyana S Khlebnicova1, Yuri A Piven1, Alexander V Baranovsky1, Fedor A Lakhvich1, Svetlana V Shishkina2, Daina Zicāne3, Zenta Tetere3, Irisa Rāviņa3, Viktors Kumpiņš3, Inese Rijkure3, Inese Mieriņa3, Uldis Peipiņš3, Māris Turks4.   

Abstract

An efficient protocol for the synthesis of novel lupane triterpenoid-indazolone hybrids with oxime ester linkage has been developed from naturally accessible precursor betulin. For the first time a series of betulonic acid-indazolone hybrids have been synthesized via an acylation of corresponding 6,7-dihydro-1H-indazol-4(5H)-one oximes with betulonic acid chloride. Diastereoselective reduction of the obtained betulonic acid conjugates with NaBH4 resulted in a formation of betulinic acid-indazolone hybrids in excellent yields. The configuration of the key compounds has been fully established by X-ray and 2D NMR analysis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Betulinic acid; Betulonic acid; Indazolone oximes; Triterpenoid-indazolone hybrids; X-ray structure

Mesh:

Substances:

Year:  2016        PMID: 27500691     DOI: 10.1016/j.steroids.2016.08.002

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  2 in total

1.  Design, synthesis and cytotoxic evaluation of novel betulonic acid-diazine derivatives as potential antitumor agents.

Authors:  Yisong Shu; Feifei Li; Yaotian Han; Penglong Wang; Feng Gao; Mengmeng Yan; Miao Liang; Qiang Ma; Yuzhong Zhang; Xia Ding; Haimin Lei
Journal:  Front Chem       Date:  2022-09-06       Impact factor: 5.545

2.  Betulinic Acid-Azaprostanoid Hybrids: Synthesis and Pharmacological Evaluation as Anti-inflammatory Agents.

Authors:  Tatyana S Khlebnicova; Yuri A Piven; Fedor A Lakhvich; Iryna V Sorokina; Tatiana S Frolova; Dmitry S Baev; Tatyana G Tolstikova
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2020
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.